Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O P Hansen

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Anti-Cancer Drugs|December 1, 1995
Phase II study of gemcitabine in previously platinum-treated ovarian cancer patientsB Lund, O P Hansen, J P Neijt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase II study of teniposide in advanced breast cancerJ Boas, D Rasmussen, O P Hansen, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III studyD Nielsen, P Dombernowsky, S K Larsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized studyL Ovesen, L Allingstrup, J Hannibal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1992
Teniposide in advanced breast cancer. A phase II trial in patients with no prior chemotherapyD Nielsen, J Boas, S A Engelholm, et al.
Journal of the National Cancer Institute|October 19, 1994
Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patientsB Lund, O P Hansen, K Theilade, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Inter-relationships between single carbon units' metabolism and resting energy expenditure in weight-losing patients with small cell lung cancer. Effects of methionine supply and chemotherapyH Sengeløv, O P Hansen, L Simonsen, et al.
Ugeskrift for Laeger|February 26, 1996
[Treatment of primary breast cancer. Consequences of mammographic screening in the municipality of Copenhagen]F R Hirsch, H T Mouridsen, O P Hansen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Ceftriaxone versus latamoxef in febrile neutropenic patients: empirical monotherapy in patients with solid tumoursP S Oturai, N H Holländer, O P Hansen, et al.
Leukemia|June 1, 1991
Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, DenmarkO P Hansen, J Pedersen-Bjergaard, J Ellegaard, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Anti-Cancer Drugs|December 1, 1995
Phase II study of gemcitabine in previously platinum-treated ovarian cancer patientsB Lund, O P Hansen, J P Neijt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase II study of teniposide in advanced breast cancerJ Boas, D Rasmussen, O P Hansen, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III studyD Nielsen, P Dombernowsky, S K Larsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized studyL Ovesen, L Allingstrup, J Hannibal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1992
Teniposide in advanced breast cancer. A phase II trial in patients with no prior chemotherapyD Nielsen, J Boas, S A Engelholm, et al.
Journal of the National Cancer Institute|October 19, 1994
Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patientsB Lund, O P Hansen, K Theilade, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Inter-relationships between single carbon units' metabolism and resting energy expenditure in weight-losing patients with small cell lung cancer. Effects of methionine supply and chemotherapyH Sengeløv, O P Hansen, L Simonsen, et al.
Ugeskrift for Laeger|February 26, 1996
[Treatment of primary breast cancer. Consequences of mammographic screening in the municipality of Copenhagen]F R Hirsch, H T Mouridsen, O P Hansen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Ceftriaxone versus latamoxef in febrile neutropenic patients: empirical monotherapy in patients with solid tumoursP S Oturai, N H Holländer, O P Hansen, et al.
Leukemia|June 1, 1991
Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, DenmarkO P Hansen, J Pedersen-Bjergaard, J Ellegaard, et al.
Pageof 6